Consistent with our expectations, our in vitro and in vivo studies revealed that adiponectin can strongly promote pancreatic cancer cell growth via the inhibition of apoptosis, and we simultaneously investigated the underlying molecular mechanisms. This evidence concerns the gene ADIPOQ and familial pancreatic carcinoma.